190 related articles for article (PubMed ID: 6383127)
1. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
Trübestein G; Balzer K; Bisler H; Klüken N; Muller-Wiefel H; Unkel B; Mahfoud Y; Ziegler W
Angiology; 1984 Aug; 35(8):500-5. PubMed ID: 6383127
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
Van den Brande P; Maurel A
Angiology; 1998 Feb; 49(2):105-14. PubMed ID: 9482510
[TBL] [Abstract][Full Text] [Related]
3. Buflomedil for intermittent claudication.
De Backer TL; Vander Stichele RH; Bogaert MG
Cochrane Database Syst Rev; 2001; (1):CD000988. PubMed ID: 11279700
[TBL] [Abstract][Full Text] [Related]
4. A review of long-term safety data with buflomedil.
Bachand RT; Dubourg AY
J Int Med Res; 1990; 18(3):245-52. PubMed ID: 2193838
[TBL] [Abstract][Full Text] [Related]
5. [Buflomedil in arterial occlusive disease. Results of a controlled study].
Trübestein G; Balzer K; Bisler H; Klüken N; Mahfoud Y; Müller-Wiefel H; Unkel B; Ziegler W
Dtsch Med Wochenschr; 1982 Dec; 107(51-52):1957-61. PubMed ID: 6756854
[No Abstract] [Full Text] [Related]
6. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
Andreozzi GM; Lepore R
Clin Ter; 1990 Nov; 135(4):273-81. PubMed ID: 2150026
[TBL] [Abstract][Full Text] [Related]
7. Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study.
Trübestein G; Böhme H; Heidrich H; Heinrich F; Hirche H; Maass U; Mörl H; Rudofsky G
Angiology; 1984 Nov; 35(11):701-8. PubMed ID: 6388425
[TBL] [Abstract][Full Text] [Related]
8. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
Sunder-Plassmann L; Gandolfo AM; Utz C
MMW Munch Med Wochenschr; 1984 Mar; 126(9):247-8. PubMed ID: 6425678
[No Abstract] [Full Text] [Related]
10. Buflomedil for intermittent claudication.
de Backer TL; Bogaert M; Vander Stichele R
Cochrane Database Syst Rev; 2007 Oct; (4):CD000988. PubMed ID: 17943749
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
Walker GA; Mac Hannaford JC
Fundam Clin Pharmacol; 1995; 9(4):387-94. PubMed ID: 8566940
[TBL] [Abstract][Full Text] [Related]
12. Buflomedil for intermittent claudication.
de Backer TL; Bogaert M; Vander Stichele R
Cochrane Database Syst Rev; 2008 Jan; (1):CD000988. PubMed ID: 18253982
[TBL] [Abstract][Full Text] [Related]
13. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
Forconi S; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Ralli L; Guerrini M; Di Perri T
J Int Med Res; 1984; 12(3):188-92. PubMed ID: 6734922
[No Abstract] [Full Text] [Related]
14. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
Diehm C; Eckstein M; Hübsch-Müller C
Vasa; 1989; 18(1):40-7. PubMed ID: 2648691
[TBL] [Abstract][Full Text] [Related]
15. Buflomedil for intermittent claudication.
de Backer TL; Vander Stichele R
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD000988. PubMed ID: 23543509
[TBL] [Abstract][Full Text] [Related]
16. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
17. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
Diamantopoulos EJ; Grigoriadou M; Ifanti G; Raptis SA
Int Angiol; 2001 Dec; 20(4):337-44. PubMed ID: 11782701
[TBL] [Abstract][Full Text] [Related]
18. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
[TBL] [Abstract][Full Text] [Related]
19. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
Fonseca V; Mikhailidis DP; Barradas MA; Jeremy JY; Gracey L; Dandona P
Int J Clin Pharmacol Res; 1988; 8(5):377-81. PubMed ID: 3229875
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
